229 related articles for article (PubMed ID: 17722163)
1. [Nausea and vomiting in oncologic therapy. Guidelines for use of setrone].
Nemec K
Pharm Unserer Zeit; 2007; 36(5):362-7. PubMed ID: 17722163
[No Abstract] [Full Text] [Related]
2. Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?
de Wit R; Aapro M; Blower PR
Cancer Chemother Pharmacol; 2005 Sep; 56(3):231-8. PubMed ID: 15838653
[TBL] [Abstract][Full Text] [Related]
3. Antiemetic drugs.
Cranwell-Bruce L
Medsurg Nurs; 2009; 18(5):309-13; quiz 314. PubMed ID: 19927970
[No Abstract] [Full Text] [Related]
4. Mechanism of action of 5-HT3 receptor antagonists: clinical overview and nursing implications.
Bremerkamp M
Clin J Oncol Nurs; 2000; 4(5):201-7. PubMed ID: 11111451
[TBL] [Abstract][Full Text] [Related]
5. 5-hydroxytryptamine type-3 receptor antagonists for chemotherapy-induced and radiotherapy-induced nausea and emesis: can we safely reduce the dose of administered agents?
Aapro M; Blower P
Cancer; 2005 Jul; 104(1):1-18. PubMed ID: 15929119
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-induced nausea and vomiting: antiemetic trials that impacted clinical practice.
Trigg ME; Higa GM
J Oncol Pharm Pract; 2010 Dec; 16(4):233-44. PubMed ID: 20085961
[TBL] [Abstract][Full Text] [Related]
7. NCCN antiemesis guidelines emphasize 'delayed' emesis, new 5-HT3 inhibitors, and NK-1 blockers.
National Comprehensive Cancer Network (NCCN)
J Support Oncol; 2004; 2(4):366. PubMed ID: 15357520
[No Abstract] [Full Text] [Related]
8. DAB: a three-drug combination provides alternative to 5-HT3 receptor drugs.
McDermott M
Oncol Nurs Forum; 1995 May; 22(4):718. PubMed ID: 7675677
[No Abstract] [Full Text] [Related]
9. [Pharmacology and clinical experiences with serotonin (5-HT3) receptor antagonists].
Scholz J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Oct; 32(10):626-8. PubMed ID: 9445561
[No Abstract] [Full Text] [Related]
10. Antiemetic strategies for high-dose chemoradiotherapy-induced nausea and vomiting.
Spitzer TR; Grunberg SM; Dicato MA
Support Care Cancer; 1998 May; 6(3):233-6. PubMed ID: 9629875
[TBL] [Abstract][Full Text] [Related]
11. Evolving paradigms in chemotherapy-induced nausea and vomiting and symptom management for the breast cancer patient.
Biedrzycki BA
ONS Connect; 2007; 22(8 Suppl):9-10. PubMed ID: 17824543
[No Abstract] [Full Text] [Related]
12. Re: 5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy.
Hartvig P
J Oncol Pharm Pract; 2007 Mar; 13(1):57-8. PubMed ID: 17621570
[No Abstract] [Full Text] [Related]
13. Blueprint for the control of radiation-induced nausea and vomiting. Discussion.
Horiot JC
Acta Oncol; 2004 Sep; 43 Suppl 15():23-4. PubMed ID: 15370627
[No Abstract] [Full Text] [Related]
14. [Serotonin antagonists against nausea and vomiting induced by oncologic therapy].
Mella O; Dahl O
Tidsskr Nor Laegeforen; 1993 Aug; 113(18):2233-4. PubMed ID: 8362384
[No Abstract] [Full Text] [Related]
15. Anti-emetic therapy in cancer chemotherapy: current status.
Herrstedt J; Dombernowsky P
Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):143-50. PubMed ID: 17697032
[TBL] [Abstract][Full Text] [Related]
16. Patients' experiences of chemotherapy treatment.
Colbourne L
Prof Nurse; 1995 Apr; 10(7):439-42. PubMed ID: 7724633
[TBL] [Abstract][Full Text] [Related]
17. [Guidelines for prophylaxis and treatment of chemotherapy-induced nausea and vomiting].
Durand JP; Madelaine I; Scotté F
Bull Cancer; 2009 Oct; 96(10):951-60. PubMed ID: 19734117
[TBL] [Abstract][Full Text] [Related]
18. In search of the ideal antiemetic.
Seegenschmiedt MH
Acta Oncol; 2004 Sep; 43 Suppl 15():13-8. PubMed ID: 15370625
[No Abstract] [Full Text] [Related]
19. [From cocaine to innovative antiemetics. The medicinal chemistry of 5-ht3 receptor antagonists].
Zettl H; Schubert-Zsilavecz M; Siebert CD
Pharm Unserer Zeit; 2007; 36(5):354-61. PubMed ID: 17722162
[No Abstract] [Full Text] [Related]
20. [Treatment of chemotherapy-induced nausea].
Heikkinen M
Duodecim; 1993; 109(10):913-5. PubMed ID: 8062658
[No Abstract] [Full Text] [Related]
[Next] [New Search]
